Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 417

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies

Open access
Feng, Gong, Zheng, Kenneth I., Yan, Qin-Qin, Rios, Rafael S., Targher, Giovanni, Byrne, Christopher D., Poucke, Sven Van, Liu, Wen-Yue, Zheng, Ming-Hua·2020·Journal of Clinical and Translational Hepatology

Abstract

The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide attention. Cases of liver damage or dysfunction (mainly characterized by moderately elevated serum aspartate aminotransferase levels) have been reported among patients with COVID-19. However, it is currently uncertain whether the COVID-19-related liver damage/dysfunction is due mainly to the viral infection per se or other coexisting conditions, such as the use of potentially hepatotoxic drugs and the coexistence of systemic inflammatory response, respiratory distress syndrome-induced hypoxia, and multiple organ dysfunction. Based on the current evidence from case reports and case series, this review article focuses on the demographic and clinical characteristics, potential mechanisms, and treatment options for COVID-19-related liver dysfunction. This review also describes the geographical and demographic distribution of COVID-19-related liver dysfunction, as well as possible underlying mechanisms linking COVID-19 to liver dysfunction, in order to facilitate future drug development, prevention, and control measures for COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14218/jcth.2020.00018

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 417

Metadata

Authors
Feng, G., Zheng, K. I., Yan, Q.-Q., Rios, R. S., Targher, G., Byrne, C. D., Poucke, S. V., Liu, W.-Y., & Zheng, M.-H.
Venue
Journal of Clinical and Translational Hepatology
Published
2020-03-28
Volume
8
Issue
1
Pages
1-7
ISSN
  • 2225-0719 (ISSN-L)
  • 2310-8819
OpenAlex
W3013727805
Cited by
417
References
38
FWCI
11.62
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. https://app.cochat.ai/papers/10.14218/jcth.2020.00018
The paper
Feng, G., Zheng, K. I., Yan, Q.-Q., Rios, R. S., Targher, G., Byrne, C. D., Poucke, S. V., Liu, W.-Y., & Zheng, M.-H. (2020). COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. Journal of Clinical and Translational Hepatology. https://doi.org/10.14218/jcth.2020.00018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.